How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on: May 09,2024

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on:May 09,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on: February 20,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on:February 20,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on: January 29,2024

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Updated on:January 29,2024

Mouth cancer cases hit new record in England and Scotland—what you need to know

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainCases of mouth cancer have reached a record high in England and Scotland, a newreport shows. Last year, there were more

Updated on: November 30,2024

Mouth cancer cases hit new record in England and Scotland—what you need to know

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainCases of mouth cancer have reached a record high in England and Scotland, a newreport shows. Last year, there were more

Updated on:November 30,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on: January 25,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on:January 25,2024

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Updated on: November 11,2024

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Updated on:November 11,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on: January 22,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on:January 22,2024

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered

Updated on: July 08,2024

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered

Updated on:July 08,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on: March 25,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on:March 25,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on: January 30,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on:January 30,2024

Existing cancer drug ponatinib could be repurposed to fight certain aggressive cancers

byNanyang Technological UniversitySchematic summary of mechanisms of action of ponatinib in ALT cells. Ponatinib disrupts alternative lengthening of telomeres mechanisms by inducing telomeric C-

Updated on: January 10,2024

Existing cancer drug ponatinib could be repurposed to fight certain aggressive cancers

byNanyang Technological UniversitySchematic summary of mechanisms of action of ponatinib in ALT cells. Ponatinib disrupts alternative lengthening of telomeres mechanisms by inducing telomeric C-

Updated on:January 10,2024